DHL Group Acquires CRYOPDP from Cryoport to Strengthen DHL Health Logistics

March 31, 2025

DHL Group will acquire 100% of CRYOPDP, a specialty courier focused on clinical trials, biopharma, and cell & gene therapies. DHL says the deal strengthens its specialty pharma logistics capabilities and supports its Strategy 2030 ambition to lead in life sciences and healthcare logistics.

Buyers
DHL Group, DHL Supply Chain
Targets
CRYOPDP
Sellers
Cryoport, Inc.
Location
Germany
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.